According to a new report by Expert Market Research, the Geographic Atrophy Market was valued at USD 25.47 Billion in 2025 and is expected to grow at a CAGR of 5.7% during 2026-2035, reaching USD 44.34 Billion by 2035. Furthermore, the study highlights evolving treatment approaches and rising healthcare focus.

The detailed analysis from Expert Market Research reviews key industry factors. Moreover, it examines changing treatment demand, patient awareness, and advancements in therapeutic development.

Additionally, market growth is supported by increasing attention toward eye health and innovative therapies. Therefore, companies are focusing on research collaborations, new treatment pathways, and improved solutions for patients with geographic atrophy.

View a Sample Report – Includes Full Table of Contents

Overall, the market outlook remains positive as healthcare systems emphasize diagnosis and management. Consequently, Expert Market Research identifies strong opportunities through technology advancement, clinical progress, and expanding treatment options.

Market Overview

Geographic atrophy is a progressive eye condition linked with retinal cell damage and vision decline. Furthermore, the condition mainly affects older adults, creating demand for effective healthcare solutions. Moreover, increasing awareness encourages earlier diagnosis and supports market expansion.

The industry is influenced by growing research activity and therapeutic innovation. Additionally, Expert Market Research observes that emerging biological and advanced treatment approaches are shaping future development. Thus, manufacturers continue improving product pipelines and healthcare accessibility.

Market Size and Forecast Analysis

According to Expert Market Research projections, the Geographic Atrophy Market reached USD 25.47 Billion in the base year 2025. Furthermore, the market is anticipated to expand at a CAGR of 5.7% during 2026-2035. Consequently, the forecast value is expected to reach USD 44.34 Billion by 2035.

Macroeconomic and Industry Linkage Analysis

Healthcare investment and demographic changes influence the market landscape. Moreover, increasing attention toward age-related eye conditions encourages innovation across pharmaceutical and biotechnology sectors. Therefore, companies are developing solutions that address unmet patient needs.

Additionally, regulatory support and scientific progress contribute to industry momentum. Meanwhile, Expert Market Research notes that collaborations between organizations can strengthen research capabilities and accelerate therapeutic development.

Key Growth Drivers

• Rising Disease Awareness: Furthermore, increased knowledge about geographic atrophy encourages timely diagnosis and treatment discussions.
• Advancing Therapies: Additionally, new therapeutic research supports improved options for patients and healthcare providers.
• Aging Population Needs: Moreover, growing demand among older adults supports continued market development.
• Research Collaborations: Therefore, partnerships help companies expand treatment innovation and clinical progress.
• Healthcare Focus: Overall, stronger attention toward vision care creates favorable market conditions.

Market Trends

Currently, the market is moving toward innovative medicines and advanced therapeutic platforms. Furthermore, companies are exploring biologic approaches and other solutions to improve patient outcomes. Additionally, strategic collaborations are becoming important for industry progress.

Moreover, digital healthcare awareness and improved diagnosis practices influence market direction. Similarly, Expert Market Research highlights continued interest in expanding treatment availability and strengthening healthcare delivery.

Market Challenges and Risk Factors

However, the market faces challenges related to treatment complexity and development requirements. Additionally, healthcare providers must manage patient needs while adapting to evolving therapeutic methods. Therefore, careful planning remains important.

Furthermore, competition among innovators and the need for effective solutions can create pressure within the industry. Nevertheless, ongoing research provides opportunities to address these limitations.

Market Opportunities and White Space Areas

Moreover, emerging treatment technologies offer significant opportunities for future expansion. Additionally, companies can explore innovative approaches that improve patient support and therapeutic outcomes. Thus, the market has room for continued advancement.

Furthermore, expanding healthcare infrastructure creates new possibilities across regions. Consequently, Expert Market Research identifies opportunities through partnerships, product innovation, and improved access to care.

Value Chain and Supply Chain Analysis

The value chain includes research organizations, therapy developers, healthcare providers, and distribution networks. Moreover, efficient coordination supports product availability and market growth. Therefore, strong supplier relationships remain essential for sustainable development.

Market Segmentation Analysis

Age Group

• 60-75 Years
• Above 75 Years

Treatment

• Medications
• Supplements
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Region

• United States
• EU-4 and the United Kingdom
• Japan
• India

Competitive Landscape

The competitive landscape includes leading organizations focused on innovation and treatment development. Furthermore, Expert Market Research identifies Apellis Pharmaceuticals, Inc., Iveric Bio, Alkeus Pharmaceuticals Inc., Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Novartis AG, Regenerative Patch Technologies, LLC, F. Hoffmann-La Roche AG, Gensight Biologics, NGM Biopharmaceuticals, AstraZeneca PLC, and Lineage Cell Therapeutics as key companies.

Frequently Asked Questions (FAQs)

What is the current size of the Geographic Atrophy Market?
Furthermore, the Geographic Atrophy Market size was USD 25.47 Billion in 2025.

What is the projected CAGR of the Geographic Atrophy Market?
Additionally, the Geographic Atrophy Market is projected to grow at a CAGR of 5.7% during 2026-2035.

Which region dominates the Geographic Atrophy Market?
Moreover, regional analysis covers the United States, EU-4 and the United Kingdom, Japan, and India.

Who are the key players in the Geographic Atrophy Market?
Furthermore, key players include Apellis Pharmaceuticals, Inc., Iveric Bio, Alkeus Pharmaceuticals Inc., Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Novartis AG, Regenerative Patch Technologies, LLC, F. Hoffmann-La Roche AG, Gensight Biologics, NGM Biopharmaceuticals, AstraZeneca PLC, and Lineage Cell Therapeutics.

What are the major growth drivers of the Geographic Atrophy Market?
Additionally, major drivers include disease awareness, treatment innovation, healthcare focus, and research development.

What are the key segments of the Geographic Atrophy Market?
Moreover, key segments include age group, treatment, distribution channel, and region.

What challenges does the Geographic Atrophy Market face?
However, challenges include treatment complexity, development needs, and competitive pressures.

What is the forecast value of the Geographic Atrophy Market by 2035?
Finally, the forecast value of the Geographic Atrophy Market is USD 44.34 Billion by 2035.

”

About Us:

Expert Market Research is a leading market intelligence and consulting platform delivering data-driven insights across commodities, chemicals, energy, and industrial markets. Our research helps businesses, analysts, investors, and procurement teams understand price trends, supply-demand dynamics, competitive landscapes, benchmark best practices, and develop long-term market strategies.

Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.

Media Contact:

Company Name: Expert Market Research
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com